Many neurotransmitters exert their actions on neurons by stimulating the formation of intracellular second messengers, which include such diverse molecules as cyclic nucleotides, Ca 2+, inositol 1,4,5-trisphosphate and 1,2-diacylglycerol. In most cases second messengers stimulate the activity of specific protein kinases, which phosphorylate and hence modulate the activity of a large number of enzymes, membrane ion channels and structural proteins (for review, see Ref. 1). However, second messengers can also activate phosphatases either directly (as in the case of the Ca2+-calmodulin-dependent phosphatase calcineurin), or indirectly through phosphorylation of phosphatase inhibitors 2. In some cases, second messengers can act without the participation of enzyme intermediates, by binding to membrane ion channels (or to regulatory proteins closely associated with them) and changing their properties (for instance in the case of Ca2+-activated K + channels; for review, see Ref.
3). Recent work has suggested that the membrane polyunsaturated fatty acid arachidonic acid and its metabolites produced through the lipoxygenase pathways may constitute a novel class of neuronal second messengers. These lipids, which affect the activities of neuronal ion channels and protein kinases, might participate in the regulation of neurotransmitter release.
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Arachidonic acid is found in esterified form in cell membrane phospholipids from which it can be liberated through multiple enzymatic pathways (see Box 1) . It can then diffuse out of the cell, be reincorporated into phospholipids, or undergo metabolism. Three pathways of arachidonic acid metabolism have been described in animal tissues: the cyclooxygenase pathway, the lipoxygenase pathway and the cytochrome P-450 or 'epoxygenase' pathway (Box 1). In nervous tissue the major enzymatic route involved in the metabolism of arachidonic acid is the 12-lipoxygenase pathway (Box 1 and Fig. 1 ). There is also good evidence for the occurrence in nervous tissue of the 5-1ipoxygenase pathway.
12-Lipoxygenase, first isolated from blood platelets and now purified to near homogeneity from leukocytes, is a cytosolic protein of 72 kDa (based on SDSpolyacrylamide gel electrophoresis) and has no apparent cofactor requirement 4. A cDNA encoding leukocyte 12-1ipoxygenase has been isolated and sequenced 5. Like all other lipoxygenases, 12-lipoxygenase catalyses the introduction of molecular oxygen into a 1,4-(cis,cis)-pentadiene moiety, converting arachidonic acid into the hydroperoxide, (12s)-hydroperoxyeicosatetraenoic acid (12-HPETE) -a reaction that is both regiospecific and stereospecific. Other cis-polyunsaturated fatty acids, such as linoleic acid, linolenic acid and docosahexaenoic acid are also good substrates for the leukocyte 12-1ipoxygenase.
Lipoxygenases in the brain
In a recent study the levels of 12-1ipoxygenase in several areas of porcine brain were estimated by immunoassay, using a monoclonal antibody raised against leukocyte 12-1ipoxygenase °. Detectable levels of the enzyme were found in the cytosolic fractions of olfactory bulb, hypothalamus, cerebellum and pineal body; the highest |evels were detected in parenchymal cells of the anterior pituitary lobe.
Even though 12-HPETE is reduced very rapidly to the alcohol (12s)-hydroxyeicosatetraenoic acid (12-HETE), which has long been known to be a major metabolite of arachidonic acid in the brain, the metabolism of 12-HPETE is not limited to its reduction (Fig. 1) . The fatty acid hydroperoxide can give rise to a group of biologically active hydroxyepoxides, the 'hepoxilins', two of which -hepoxilin As and hepoxilin I]3 -have been identified in nervous tissue from both vertebrates and invertebrates 7,s (Fig.  1) . The hepoxilins are short-lived compounds and undergo further metabolism by the action of a hepoxilin hydrolase, which has been purified from rat liver and shown to be present in brain. This enzyme catalyses the specific cleavage of the hepoxilin epoxide 
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TiPS -September 1990 [Vol. 11] Liberation of arachidonic acid from membrane phospholipids mainly occurs by two pathways (Fig. 1) . Hydrolytic cleavage at the sn-2 position of the glycerophospholipid backbone, catalysed by Ca2+-activated phospholipase A2, yields free fatty acid and lysophospholipidL Alternatively, formation of free arachidonic acid can be initiated by the activation of a phospholipase C, which cleaves the phospholipid at the phosphate ester bond, producing 1,2-diacylgJycerol. This intermediate is broken down by diacylglycerol-and monoacylglycerol lipases to yield free fatty acid and glycerol-'.
After liberation, free arachidonic acid has several fates. It can diffuse out of the cell. Alternatively, it can be either metabolized (see below) or converted to arachidonoylcoenzyme A and reincorporated into phospholipids s ( The three pathways of arachidonic acid metabolism described for other animal tissues -cycloo×ygenase, iipoxygenase and cytochrome P-450 (Ref. 4) -bdve also been found in the brain (for review, see ReL 5) . The cyclooxygenase pathway leads to the formation of prostaglandins, prostacyclin (PGI2) and thromboxane A2 (TXA2). Cyclooxygenase is inhibited by some non-steroidal antiinflammatory drugs, such as indometacin, by the antioxidant nordihydroguaiaretic acid and by the false substrate eicosatetraynoic acid 4.
Lipoxygenases, which are inhibited nonspecifically by nordihydroguaiaretic acid, eicosatetraynoic acid and baicalein, form hydroperoxyeicosatetraenoic acids (HPETE) as their primary products. HPETE can undergo a complex metabolism (see main text for details). 5-HPETE, formed by 5-1ipoxygenase, is converted to the short-lived epoxide leukotriene, LTA4, by a dehydrase activity intrinsic to 5-1ipoxygenase 6. LTA4 can be transformed either into LTB4, by an LTA4-hydrolase 7, or into LTC4 by a glutathione-S-transferase (GSH-S-transferase)8. 5-Lipoxygenase activity is specifically inhibited by 5,6-methanoleukotriene A4. methyl ester and 5,6-dehydroarachidonic acid. In addition, fo,-mation of 5-1ipoxygenase products can be inhibited in intact cells by MK886, which prevents 5-1ipoxygenase activaUon by binding to a newly described 5-1ipoxygenase activatiz:g protein (FLAP) 9. Metabolism of 15-HPETE show.~ considerable similarities to that of 12-HPETE (see Refs 10 and 11).
Cytochrome P-450 catalyses the conversion of arachidonic acid into an array of epoxyeicosatrienoic acids (EET), which are hydrolysed to the corresponding diols by the action of an epoxide hydrolase (inhibited by trichloropropene oxide). In addition, cytochrome P-450 has also been shown to produce hydroxyeicosatetraenoic acids (HETE) .2.
ring, yielding a family of isomeric trihydroxy acids termed "trioxilins '9. In addition to hepoxilins and trioxilins, the nervous tissue of the marine mollusk Aplysia californica converts 12-HPETE into the keto acid, 12-ketoeicosatetraenoic acid (12-KETE) ( Fig. 1 In Aplysia, formation of 12-HETE by neural ganglia is stimulated by the application of histamine or the tetrapeptide FMRF amide 24,25. These two modulatory substances can alter neuronal membrane potential by opening K + channels, producing presynaptic inhibition of neurotransmitter release. It is interesting, therefore, that electrical stimulation of L32 neurons, an identified group of Aplysia cells, results in the generation of both 12-HETE and hepoxilin A3 as well as in the inhibition of neurotransmitter release from LI0 neurons a,24.
Modulation of K + channels by lipoxygenase metabolites
The results obtained in Aplysia suggested that lipoxygenase metabolites of arachidonic acid may participate in the modulation of K + channel activity and in presynaptic inhibition. This idea was substantiated by electrophysiological experiments. In two histaminoceptive neurons (L10 and L14), extracellular application of 12-HPETE produced changes in membrane potential that were similar to those produced by the neurotransmitter s. Similarly, in sensory cells, arachidonic acid and 12-HPETE mimicked the actions of FMRF amide, increasing the probability of opening of a subclass of K + channels, the 5-HT-inactivated These findings raise several questions. Is 12-HPETE itself the active intracellular messenger, or does it require further metabolism? If it is metabolized, which of its products is the active one? Does this 12-1ipoxygenase-derived messenger act directly on the IK(S-HT) channel, or does it act by modulating the activity of protein kinases or protein phosphatases? In cell-free patches of Aplysia sense,~'y cell membranes, in the absence of cytosolic components, 12-HPETE could not affect the opening of IK(5-HT~ channels is. Its biological activity was restored, however, when the patches were bathed in a solution containing hematin (which catalyses the conversion of the lipid hydroperoxide to various products, including hepoxilins and 12-KETE). Thus biotransformation of 12-HPETE is necessary for biological activity. Since the experiments were carried out in the absence of ATP and GTP, they also indicate that K + channel modulation by 12-HPETE does not require the participation of a G protein or of a protein kinase; furthermore, it cannot be due to a phosphoprotein phosphatase, since it is reversible.
It is still unclear what enzyme, if any, catalyses the metabolism of 12-HPETE and what metabolite is responsible for the biological response. Belardetti and colleagues found that the ~eversible cytochrome P-450 inhibitor proadifen (SKF525A) significantly reduced the response of sensory neurons to 12-HPETE, suggesting that metabolism is carried out by a cytochrome P-450-1ike enzyme 15.
The identity of the derivative of 12-HPETE that activates IK(5_HT ) channels in Aplysia sensory cells is unknown. It is clear, however, that two of the candidates, hepoxilin A 3 and 12-KETE, have different electrophysiological actions on identified Aplysia neurons: hepoxilin A 3 hyperpolarizes the membrane of L14 cells, an effect that appears to result from increased conductance to K + ionsS; by contrast, 12-KETE produces a biphasic response (depolarization-hyperpolarization) in these neurons 1°. Hepoxilin A 3 also hyperpolarizes neurons of the CA1 area in superfused rat hippocampal slices 2s.
Recently, Buttner and coworkers reported that, although 12-HPETE is ineffective when applied to the intracellular side of the neuronal membrane, it can produce a large increase in IK(5-HT) channel activity when applied to the outside; 12-HPETE may therefore act as a local intercellular signalling molecule 29. While its tran-sient chemical nature seems to argue against this possibility, there are other examples of extremely short-lived metabolites of arachidonic acid that appear outside the cell of origin and act on membrane receptors of neighboring cells. For example, the cyclooxygenase product thromboxane A2, a powerful platelet-aggregating and vasoconstricting autacoid, is released from blood platelets and acts both on the platelets themselves and on vascular smooth muscle (in both cases via a membrane receptor) 19. It is not understood how these short-lived metabolites leave cells. Perhaps an anion carrier of the type sensitive to the uricosuric agent probenecid may be involved.
Whatever the mechanism for the release of 12-HPETE, its diffusion in a circumscribed area around the neuron of origin might bring about a local spreading of neuronal inhibition. This could represent a means of modulating or synchronizing the activity of a small ensemble of neighboring neurons involved in a single physiological function. Such a role would be analogous to the paracrine role played by the catecholamines in mammalian brain In rat hippocampal CAt neurons, somatostatin, a putative transmitter in the hippocampus, augments a non-inactivating, voltage-gated K ÷ current, termed the M current (IM). Augmentation of IM results in a slow hyperpolarization of the membrane and decreased neuronal excitability 3°. Lipoxygenase metabolites of arachidonic acid may be involved in the response to somatostatin. Schweitzer ef al. 31 found that phospholipase A2 inhibitors (mepacrine and p-bromophenacylbromide) and specific 5-1ipoxygenase inhibitors (5,6-methanoleukotriene A4 methyl ester and 5,6-dehydroarachidonic acid) inhibit the response to somatostatin in CA1 cells. In addition, stimulation of IM by somatostatin can be mimicked by the application of arachidonic acid or LTC4 (a 5-1ipoxygenase metabolite) 31.
These findings suggest that lipoxygenase-derived eicosanoids have a widespread role in reducing neuronal excitability through the regulation of K ÷ channel activity. There is also evidence that arachidonic acid regulates Ca 2+ currents in hippocampal neurons 32, chick sympathetic 3-~ and frog sympathetic neurons 34.
Inhibition of neurotransmitter release
Phosphorylation of specific proteins in the presynaptic nerve terminal participates in modulating neurotransmitter release. The state of phosphorylation of the synaptic vesicle-associated protein, synapsin I, is thought to regulate the availability of synaptic vesicles for exocytosis (for review, see Ref. 35) . In its dephosphorylated state, synapsin I may cross-link synaptic vesicles to the surrounding cytoskeletal lattice. According to this model, when synapsin I is phosphorylated on its 'tail'-region by Ca2+--calmodulin-flependen t protein kinase 1I, its interaction both with synaptic vesicles and with cytoskeletal elements is reduced, resulting in dissociation of the vesicles from the cytoskeleton. This would in turn increase the number of vesicles available for exocytosis. Therefore, reducing the state of phosphorylation of synapsin I may be a way to reduce -Box 2
Arachidonic acid in hippocampal long-term potentiation
Long-term potentiation (LTP) is a mammalian model of synaptic plasticity and information storage, which can be produced in the hippocampus by high frequency stimulation of the perforant pathway (a group of fibers connecting the entorhinal cortex to the dentate gyrus)L LTP is generally believed to consist of two phasesinduction and maintenance. Induction is initiated by the postsynaptic entry of Ca 2+, which occurs through cation channels associated with excitatory amino acid receptors of the NMDA type, and consequent activation of a Ca2+-dependent protein kinase 2-4. Maintenance appears to be produced at least partly by presynaptic mechanisms s.
Williams and collaborators ° reported that perfusion with arachidonic acid produced a transient inhibition of synaptic transmission in the dentate gyros of the anesthetized rat. They also found, however, that by combining arachidonic acid perfosion with a weak stimulation of the perforant path (unable to produce LTP per se) a long-term enhancement in synaptic strength resulted, which was indistinguishable from LTP. This effect was not inhibited by the mixed lipoxygenase/cyclooxygenase blocker nordihydroguaiaretic acid indicating that it was produced by the free fatty acid, rather than by a metabolite. In agreement with this interpretation, oleic acid, a ~onounsaturated fatty acid which is not a substrate for metabolism by lipoxygenase or cyclooxygenase, was also able to produce LTP (Ref. 7) . These findings suggest that free fatty acids, liberated by the action of a phospholipase, may play a role in the maintenance phase of LTP.
The cellular site of action of this lipid(s) is still unclear and both presynaptic 6 and glial 8 sites have been proposed. Likewise, little is known of their mechanism of action. An involvement of protein ki,-,ase C has been suggested 7 on the grounds of the ability of unsaturated fatty acids to activate this protein kinase in a Ca 2+-and phospholipid-independent fashion 9. synaptic strength independently of ion channel moddlation.
Inhibition of CaZ+-dependent protein phosphorylation may underlie some of the inhibitory actions exerted by FMRF amide in molluscan neurons. In identified neurons ot the snail Helisoma, FMRF amide reduced the release of acet3,1choline by a mechanism involving reduction of a voltagedependent Ca 2+ current, and a direct action on the secretory apparatus 36. To demonstrate the latter effect, Man-Son-Hing and co-workers clamped the intracellular Ca 2+ concentration by using the Ca 2+ chelator nitr 5, whose affinity for Ca 2+ is decreased by UV light. Illumination of Helisoma neurons preloaded with nitr 5 produced a constant, elevated internal Ca 2+ concentration and enhanced acetylcho~ine release. When FMRF amide was applied under these conditions, it still produced inhibition of neurotransmitter release, but without altering the Ca 2+ concentration. Thus FMRF amide, in addition to reducing Ca 2+ influx during the action potential, also decreases the sensitivity of the secretory apparatus to an elevated concentration of intracellular Ca 2+, possibly by affecting protein phosphorylation.
Arachidonic acid and its metabolites may regulate neurotransmitter release partly by a direct action on neuronal K + channels and partly by regulating Ca 2+-dependent protein phosphorylation within the synaptic terminal. Lipoxygenase-derived eicosanoids are potent and selective inhibitors of purified Ca2+-calmodulindependent protein kinase II (Ref. 37 ). 12-HPETE inhibited this enzyme with a half-maximal effect at a concentration of 0.7 ~t~a. By contrast, it had no effect on the activities of protein kinase C, cAMP-dependent protein kinase, the Ca2+-calmodulin-dependent protein kinases I and lII, or the Ca2+-calmodulin-activated phosphatase, calcineurin. Arachidonic acid was less potent than 12-HPETE by a factor of about 40 as an inhibitor of Ca2+-calmodulindependent kinase II. This inhibitory effect of arachidonic acid could also be demonstrated in a preparation of intact synaptic nerve endings (synaptosomes) 37.
The effects of arachidonic acid and its lnetabolites on K + channels and on Ca2+-calmodulindependent protein kinase II can be integrated in a model for the role played by these Epids in presynaptic inhibition (Fig. 2) . According to this model, free arachidonic acid generated in a receptor-dependent fashion is metabolized by 12-1ipoxygenase to form 12-HPETE, A metabolite of 12-HPETE (possibly a hepoxilin) may act by modulating the activity of K + channels, while 12-HPETE itself may inhibit Ca2+-calmodulin-dependent protein kinase II activity and reduce Ca2+-stimulated phosphorylation of synapsin I and other synapticv~icle-associated proteins. These two independent actions might be synergistic in decreasing synaptic strength.
